Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
03 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/03/3109790/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
12 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/12/3098218/35186/en/Kura-Oncology-and-Kyowa-Kirin-Report-Positive-Updated-Combination-Data-for-Ziftomenib-in-Newly-Diagnosed-AML-at-2025-European-Hematology-Association-Congress.html
06 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/06/3095021/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3092389/35186/en/Kura-Oncology-and-Kyowa-Kirin-Report-Positive-Pivotal-Ziftomenib-Monotherapy-Data-at-2025-ASCO-Annual-Meeting.html
01 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/01/3091510/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Ziftomenib-in-Adults-with-Relapsed-or-Refractory-NPM1-Mutant-AML.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3087182/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-Pivotal-Monotherapy-Data-for-Ziftomenib-in-Oral-Presentation-at-the-2025-ASCO-Annual-Meeting.html
ABOUT THIS PAGE